These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383 [TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands. Tahara-Hanaoka S; Miyamoto A; Hara A; Honda S; Shibuya K; Shibuya A Biochem Biophys Res Commun; 2005 Apr; 329(3):996-1000. PubMed ID: 15752754 [TBL] [Abstract][Full Text] [Related]
7. DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases. Chan CJ; Andrews DM; McLaughlin NM; Yagita H; Gilfillan S; Colonna M; Smyth MJ J Immunol; 2010 Jan; 184(2):902-11. PubMed ID: 20008292 [TBL] [Abstract][Full Text] [Related]
8. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells. Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979 [TBL] [Abstract][Full Text] [Related]
9. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction. Castriconi R; Dondero A; Corrias MV; Lanino E; Pende D; Moretta L; Bottino C; Moretta A Cancer Res; 2004 Dec; 64(24):9180-4. PubMed ID: 15604290 [TBL] [Abstract][Full Text] [Related]
10. The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance. Fuchs A; Colonna M Semin Cancer Biol; 2006 Oct; 16(5):359-66. PubMed ID: 16904340 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells. Seth S; Georgoudaki AM; Chambers BJ; Qiu Q; Kremmer E; Maier MK; Czeloth N; Ravens I; Foerster R; Bernhardt G J Leukoc Biol; 2009 Jul; 86(1):91-101. PubMed ID: 19380711 [TBL] [Abstract][Full Text] [Related]
12. Crystal structure of cell adhesion molecule nectin-2/CD112 and its binding to immune receptor DNAM-1/CD226. Liu J; Qian X; Chen Z; Xu X; Gao F; Zhang S; Zhang R; Qi J; Gao GF; Yan J J Immunol; 2012 Jun; 188(11):5511-20. PubMed ID: 22547693 [TBL] [Abstract][Full Text] [Related]
13. NK cells recognize and kill human glioblastoma cells with stem cell-like properties. Castriconi R; Daga A; Dondero A; Zona G; Poliani PL; Melotti A; Griffero F; Marubbi D; Spaziante R; Bellora F; Moretta L; Moretta A; Corte G; Bottino C J Immunol; 2009 Mar; 182(6):3530-9. PubMed ID: 19265131 [TBL] [Abstract][Full Text] [Related]
14. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862 [TBL] [Abstract][Full Text] [Related]
15. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction. Ardolino M; Zingoni A; Cerboni C; Cecere F; Soriani A; Iannitto ML; Santoni A Blood; 2011 May; 117(18):4778-86. PubMed ID: 21406724 [TBL] [Abstract][Full Text] [Related]
16. Cellular ligands of activating NK receptors. Bottino C; Castriconi R; Moretta L; Moretta A Trends Immunol; 2005 Apr; 26(4):221-6. PubMed ID: 15797513 [TBL] [Abstract][Full Text] [Related]
17. NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions. Morgado S; Sanchez-Correa B; Casado JG; Duran E; Gayoso I; Labella F; Solana R; Tarazona R J Innate Immun; 2011; 3(4):365-73. PubMed ID: 21576932 [TBL] [Abstract][Full Text] [Related]
18. DNAM-1: an amplifier of immune responses as a therapeutic target in various disorders. Elishmereni M; Bachelet I; Levi-Schaffer F Curr Opin Investig Drugs; 2008 May; 9(5):491-6. PubMed ID: 18465659 [TBL] [Abstract][Full Text] [Related]
19. Development and Characterization of Novel Monoclonal Antibodies Against Human DNAM-1. Okumura G; Abe F; Hirochika R; Shibuya A; Shibuya K Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):135-139. PubMed ID: 28498033 [TBL] [Abstract][Full Text] [Related]
20. DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins. de Andrade LF; Smyth MJ; Martinet L Immunol Cell Biol; 2014 Mar; 92(3):237-44. PubMed ID: 24343663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]